We are live on ! Find out more
NC

Noked Capital Portfolio holdings

AUM $946K
1-Year Est. Return 17.1%
This Fund
S&P 500
This Quarter Est. Return
+32.73%
1 Year Est. Return
-17.1%
3 Year Est. Return
+197.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.6M
AUM Growth
-$14.3M
Cap. Flow
-$32.4M
Cap. Flow %
-39.71%
Top 10 Hldgs %
71.77%
Holding
105
New
34
Increased
2
Reduced
37
Closed
24

Top Buys

Rank Stock Value
1
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
+$1.6M
2
BWAY
Brainsway
BWAY
+$568K
3
AMZN icon
Amazon
AMZN
+$466K
4
JPM icon
JPMorgan Chase
JPM
+$452K
5
BABA icon
Alibaba
BABA
+$380K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.1M
2
SEDG icon
SolarEdge
SEDG
+$6.42M
3
VTRS icon
Viatris
VTRS
+$5.67M
4
DK icon
Delek US
DK
+$1.35M
5
RY icon
Royal Bank of Canada
RY
+$605K

Sector Composition

Rank Sector Weight
1 Technology 58.02%
2 Energy 11.29%
3 Healthcare 7.68%
4 Communication Services 6%
5 Financials 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEDG icon
1
SolarEdge
SEDG
$2.74B
$38.6M 47.32%
618,119
-127,150
-17% -$6.42M
DK icon
2
Delek US
DK
$4.05B
$7.92M 9.71%
195,400
-37,000
-16% -$1.35M
MSGN
3
DELISTED
MSG Networks Inc.
MSGN
$2.89M 3.54%
139,400
– –
AAPL icon
4
Apple
AAPL
$4.46T
$2.01M 2.47%
40,700
– –
ITMR
5
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$1.96M 2.4%
178,011
– –
MSFT icon
6
Microsoft
MSFT
$3.62T
$1.77M 2.17%
13,200
-3,000
-19% -$381K
GMDA
7
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1.03M 1.27%
+203,748
New +$1.6M
GILT icon
8
Gilat Satellite Networks
GILT
$883M
$846K 1.04%
100,000
– –
RADA
9
DELISTED
Rada Electronic Industries Ltd
RADA
$840K 1.03%
255,319
– –
BREW
10
DELISTED
Craft Brew Alliance, Inc.
BREW
$676K 0.83%
48,302
– –
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.57T
$596K 0.73%
11,000
+3,000
+38% +$174K
BWAY
12
Brainsway
BWAY
$634M
$572K 0.7%
+109,000
New +$568K
META icon
13
Meta Platforms (Facebook)
META
$1.5T
$560K 0.69%
2,900
-1,100
-28% -$201K
DIS icon
14
Walt Disney
DIS
$170B
$559K 0.69%
4,000
-2,000
-33% -$265K
AMZN icon
15
Amazon
AMZN
$3.06T
$473K 0.58%
+5,000
New +$466K
CVX icon
16
Chevron
CVX
$385B
$473K 0.58%
3,800
-4,200
-53% -$508K
JPM icon
17
JPMorgan Chase
JPM
$937B
$458K 0.56%
+4,100
New +$452K
PFE icon
18
Pfizer
PFE
$143B
$433K 0.53%
10,540
– –
USB icon
19
US Bancorp
USB
$99.6B
$430K 0.53%
8,200
-8,800
-52% -$453K
JNJ icon
20
Johnson & Johnson
JNJ
$613B
$418K 0.51%
3,000
-1,300
-30% -$180K
WFC icon
21
Wells Fargo
WFC
$266B
$412K 0.51%
8,700
-6,300
-42% -$295K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.11T
$405K 0.5%
1,900
-300
-14% -$62.1K
XTLB
23
XTL Biopharmaceuticals
XTLB
$7.03M
$398K 0.49%
49,722
– –
PLD icon
24
Prologis
PLD
$135B
$384K 0.47%
+4,800
New +$365K
UNH icon
25
UnitedHealth
UNH
$377B
$378K 0.46%
+1,550
New +$373K
1
2 3 4 5

Similar funds

MC
Manteio Capital Jersey City, New Jersey $1.05M AUM
GAM
GVO Asset Management Zug, Switzerland $1.07M AUM 24.36% 1-Year Est. Return
NP
Nimble Partners San Francisco, California $556K AUM 61.7% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
VM
Value Monitoring Menlo Park, California $1.5M AUM 13.21% 1-Year Est. Return
SC
Saban Cheryl $334K AUM 44.88% 1-Year Est. Return
CL
CRV LLC Palo Alto, California $1.56M AUM 87.36% 1-Year Est. Return

Noked Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Noked Capital held 105 positions worth $81.6M, down 15% from $95.9M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Noked Capital withdrew a net $32.4M in Q2 2019, closing 24 positions and reducing 37 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 58% of assets, up from 39% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Noked Capital opened a new position in Gamida Cell Ltd. Ordinary Shares worth $1.03M.

  • Noked Capital's largest Q2 2019 buy was Gamida Cell Ltd. Ordinary Shares: 203,748 shares worth $1.03M.
  • Noked Capital added most to Alphabet (Google) Class A in Q2 2019, an estimated $174K increase.
  • Noked Capital's biggest Q2 2019 reduction was SolarEdge, cutting an estimated $6.42M.
  • Noked Capital fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $12.1M.
  • Noked Capital's ten largest holdings make up 72% of its $81.6M portfolio in Q2 2019.
  • Noked Capital opened 34 new positions and closed 24 in Q2 2019.
  • Noked Capital's portfolio value fell 15% quarter-over-quarter to $81.6M.

Based on Noked Capital's 13F filing for Q2 2019, filed 15 Aug 2019.